Psoriatic Arthritis
From the Journals
Ten-day methotrexate pause after COVID vaccine booster enhances immunity against Omicron variant
Researchers in Germany report a 10-day post-vaccination hold on methotrexate boosts immunity against Omicron without compromising safety or risk...
From the Journals
JAK inhibitors show no excess cardiovascular safety signal in French nationwide cohort
Compared with adalimumab, JAK inhibitors presented no higher risk of major adverse cardiovascular events or venous thromboembolism in patients...
Opinion
A White female presented with pustules and erythematous macules on the left palm
A 53-year-old White female presented with itchy pustules and erythematous macules on the left palm.
From the Journals
Previous endemic coronavirus encounters linked with long COVID
Long COVID may be an unusual response to previously encountered non–SARS-CoV-2 coronaviruses, researchers report.
From the Journals
Analysis of PsA guidelines reveals much room for improvement on conflicts of interest
Researchers show that a majority of the authors of the most recent psoriatic arthritis clinical practice guidelines from the American College of...
Conference Coverage
Sex differences seen in inflammatory arthritis health care use
Women’s higher risk of conditions such as osteoarthritis and pain and fatigue may help to explain why overall healthcare resource use was higher...
From the Journals
Psoriasis, psoriatic arthritis insurance coverage remains restrictive
A database review showed restrictive coverage of specialty medications for psoriatic disease beyond the label indications.
Latest News
Apremilast alleviates severe psoriasis in some children, data show
“In this randomized, placebo-controlled trial, oral apremilast demonstrated effectiveness and was well tolerated.”
Latest News
Brodalumab suicide risk similar to other biologics, postmarket study finds
The researchers extracted data through the end of 2021 on the number of completed suicides for brodalumab and ten other biologics approved for...
From the Journals
Autoimmune diseases linked to spike in post-MI events
“People with rheumatic arthritis, when they have a heart attack, are less likely to get the standard kind of treatments and have worse outcomes...
Latest News
Sustained response at 2 years reported for newly approved oral psoriasis agent
Long-term results with the JAK inhibitor for psoriasis show responses persist.